WEALTH ENHANCEMENT ADVISORY SERVICES, LLC
Position in MRK — Merck & Co., Inc.
CIK 1632972
PLYMOUTH, MN
Position in MRK
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$208,880,733
+$36,668,277 QoQ
Shares Held
1,625,531
+13.5% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#132
of 3,769 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $1,542,735,587 across 15 Drug Manufacturers - General names. MRK ranks #3 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,833,813 | $465,733,487 | |
| 2 | LLY |
ELI LILLY & Co
|
183,702 | $220,337,708 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
1,625,531 | $208,880,733 | |
| 4 | AMGN |
Amgen Inc
|
464,220 | $168,103,346 | |
| 5 | ABBV |
AbbVie Inc.
|
576,543 | $145,081,280 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,764,695 | $101,681,725 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
603,836 | $76,288,640 | |
| 8 | PFE |
Pfizer Inc
|
3,158,575 | $76,058,486 |
All Filings in MRK
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $208,880,733 | 1,625,531 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $172,212,456 | 1,431,644 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $189,197,902 | 1,797,434 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $147,779,579 | 1,760,748 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $131,622,419 | 1,662,739 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $147,826,013 | 1,646,903 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $155,237,644 | 1,560,491 | Shares | Sole | 2025-03-17 | |
| 2024-09-30 | $150,871,727 | 1,328,564 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $156,498,303 | 1,264,122 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $161,655,771 | 1,225,129 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $130,146,113 | 1,193,782 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $110,977,732 | 1,077,977 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $14,663,645 | 127,079 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $14,142,316 | 132,929 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $10,263,318 | 92,504 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $493,553 | 5,731 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $7,141,710 | 78,334 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $8,103,093 | 98,758 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $7,313,372 | 95,425 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $14,429,982 | 192,118 | Shares | Sole | 2021-11-03 | |
| No filing history on record for this holder in this stock. | ||||||